iBio (IBIO) Enterprise Value (2016 - 2025)
iBio (IBIO) has disclosed Enterprise Value for 16 consecutive years, with -$52.7 million as the latest value for Q4 2025.
- On a quarterly basis, Enterprise Value fell 653.23% to -$52.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$52.7 million, a 653.23% decrease, with the full-year FY2025 number at -$8.6 million, up 39.61% from a year prior.
- Enterprise Value was -$52.7 million for Q4 2025 at iBio, down from -$49.6 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$3.8 million in Q4 2023 to a low of -$97.0 million in Q2 2021.
- A 5-year average of -$30.4 million and a median of -$12.6 million in 2024 define the central range for Enterprise Value.
- Peak YoY movement for Enterprise Value: tumbled 742.29% in 2021, then surged 86.49% in 2023.
- iBio's Enterprise Value stood at -$57.4 million in 2021, then skyrocketed by 83.22% to -$9.6 million in 2022, then soared by 60.05% to -$3.8 million in 2023, then plummeted by 82.05% to -$7.0 million in 2024, then plummeted by 653.23% to -$52.7 million in 2025.
- Per Business Quant, the three most recent readings for IBIO's Enterprise Value are -$52.7 million (Q4 2025), -$49.6 million (Q3 2025), and -$8.6 million (Q2 2025).